{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T02:20:04Z","timestamp":1769653204441,"version":"3.49.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clinthera.2025.11.008","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T12:38:32Z","timestamp":1765197512000},"page":"121-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Leukocytoclastic Vasculitis and Profound Cytopenias Following Teicoplanin Therapy: A Case Report on Glycopeptide Cross-Reactivity"],"prefix":"10.1016","volume":"48","author":[{"given":"Qimei","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinshuang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2025.11.008_bib0001","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/BF01715507","article-title":"Teicoplanin: 10 years of clinical experience","volume":"22","author":"Trautmann","year":"1994","journal-title":"Infection"},{"key":"10.1016\/j.clinthera.2025.11.008_bib0002","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2165\/00003495-200464090-00001","article-title":"Glycopeptide antibiotics: from conventional molecules to new derivatives","volume":"64","author":"Van Bambeke","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2025.11.008_bib0003","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.anai.2020.05.006","article-title":"Teicoplanin-induced immediate and delayed hypersensitivity reactions","volume":"125","author":"Harper","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clinthera.2025.11.008_bib0004","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1345\/aph.1H633","article-title":"Glycopeptide-induced neutropenia: cross-reactivity between vancomycin and teicoplanin","volume":"41","author":"Hsiao","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2025.11.008_bib0005","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2710.2011.01291.x","article-title":"High risk of cross-reactivity between vancomycin and sequential teicoplanin therapy","volume":"37","author":"Hsiao","year":"2012","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.clinthera.2025.11.008_bib0006","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1684\/ejd.2014.2425","article-title":"Teicoplanin-induced purpuric eruption with leukocytoclastic vasculitis","volume":"24","author":"Uchida","year":"2014","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clinthera.2025.11.008_bib0007","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2141.2005.05430.x","article-title":"Teicoplanin-dependent antibodies: detection and characterization","volume":"129","author":"Garner","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clinthera.2025.11.008_bib0008","doi-asserted-by":"crossref","DOI":"10.1177\/10600280221078123","article-title":"Thrombocytopenia associated with teicoplanin use: a retrospective observational study","author":"Elajez","year":"2022","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2025.11.008_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiac.2024.08.026","article-title":"The use of concomitant medications on nephrotoxicity associated with teicoplanin: a retrospective observational study","volume":"31","author":"Shimizu","year":"2025","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.clinthera.2025.11.008_bib0010","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.3324\/haematol.2021.279484","article-title":"Treatment of drug-induced immune thrombocytopenias","volume":"107","author":"Marini","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.clinthera.2025.11.008_bib0011","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1182\/asheducation-2009.1.153","article-title":"Drug-induced thrombocytopenia: pathogenesis, evaluation, and management","author":"George","year":"2009","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.clinthera.2025.11.008_bib0012","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1007\/s00277-015-2485-x","article-title":"Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged \u2265 65 years with immune thrombocytopenia","volume":"94","author":"Michel","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clinthera.2025.11.008_bib0013","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1182\/blood.2022017634","article-title":"How I diagnose and treat thrombocytopenia in geriatric patients","volume":"143","author":"Foy","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.clinthera.2025.11.008_bib0014","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/jcpt.12159","article-title":"Stevens-Johnson syndrome induced by the cross-reactivity between teicoplanin and vancomycin","volume":"39","author":"Yang","year":"2014","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.clinthera.2025.11.008_bib0015","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.clinthera.2009.09.010","article-title":"Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: a retrospective chart review","volume":"31","author":"Hung","year":"2009","journal-title":"Clin Ther"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291825003923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291825003923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T14:22:42Z","timestamp":1769610162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291825003923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0149291825003923"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2025.11.008","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leukocytoclastic Vasculitis and Profound Cytopenias Following Teicoplanin Therapy: A Case Report on Glycopeptide Cross-Reactivity","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2025.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}